BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boxberger KH, Hagenbuch B, Lampe JN. Ligand-dependent modulation of hOCT1 transport reveals discrete ligand binding sites within the substrate translocation channel. Biochem Pharmacol 2018;156:371-84. [PMID: 30138624 DOI: 10.1016/j.bcp.2018.08.028] [Cited by in Crossref: 17] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Nies AT, Schaeffeler E, Schwab M. Hepatic solute carrier transporters and drug therapy: Regulation of expression and impact of genetic variation. Pharmacology & Therapeutics 2022;238:108268. [DOI: 10.1016/j.pharmthera.2022.108268] [Reference Citation Analysis]
2 Schnegelberger RD, Steiert B, Sandoval PJ, Hagenbuch B. Using a competitive counterflow assay to identify novel cationic substrates of OATP1B1 and OATP1B3. Front Physiol 2022;13:969363. [DOI: 10.3389/fphys.2022.969363] [Reference Citation Analysis]
3 Meyer MJ, Schreier PCF, Basaran M, Vlasova S, Seitz T, Brockmöller J, Zdrazil B, Tzvetkov MV. Amino acids in transmembrane helix 1 confer major functional differences between human and mouse orthologs of the polyspecific membrane transporter OCT1. J Biol Chem 2022;:101974. [PMID: 35469921 DOI: 10.1016/j.jbc.2022.101974] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Ameijeiras Rodríguez C, Henriques SC, Sancho-Araiz A, Trocóniz IF, Almeida L, Silva NE. Untangling Absorption Mechanisms and Variability in Bioequivalence Studies Using Population Analysis. Pharm Res 2021. [PMID: 34932170 DOI: 10.1007/s11095-021-03136-3] [Reference Citation Analysis]
5 Gebauer L, Arul Murugan N, Jensen O, Brockmöller J, Rafehi M. Molecular basis for stereoselective transport of fenoterol by the organic cation transporters 1 and 2. Biochem Pharmacol 2021;197:114871. [PMID: 34902340 DOI: 10.1016/j.bcp.2021.114871] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
6 Meyer MJ, Tzvetkov MV. OCT1 Polyspecificity-Friend or Foe? Front Pharmacol 2021;12:698153. [PMID: 34149437 DOI: 10.3389/fphar.2021.698153] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Haberkorn B, Fromm MF, König J. Transport of Drugs and Endogenous Compounds Mediated by Human OCT1: Studies in Single- and Double-Transfected Cell Models. Front Pharmacol 2021;12:662535. [PMID: 33967805 DOI: 10.3389/fphar.2021.662535] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
8 Koepsell H. General Overview of Organic Cation Transporters in Brain. Berlin: Springer Berlin Heidelberg; 2021. [DOI: 10.1007/164_2021_449] [Cited by in Crossref: 14] [Cited by in F6Publishing: 1] [Article Influence: 14.0] [Reference Citation Analysis]
9 Zhou S, Zeng S, Shu Y. Drug-Drug Interactions at Organic Cation Transporter 1. Front Pharmacol 2021;12:628705. [PMID: 33679412 DOI: 10.3389/fphar.2021.628705] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
10 Ruggiero MJ, Malhotra S, Fenton AW, Swint-Kruse L, Karanicolas J, Hagenbuch B. A clinically relevant polymorphism in the Na+/taurocholate cotransporting polypeptide (NTCP) occurs at a rheostat position. J Biol Chem 2021;296:100047. [PMID: 33168628 DOI: 10.1074/jbc.RA120.014889] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
11 Meyer MJ, Tuerkova A, Römer S, Wenzel C, Seitz T, Gaedcke J, Oswald S, Brockmöller J, Zdrazil B, Tzvetkov MV. Differences in Metformin and Thiamine Uptake between Human and Mouse Organic Cation Transporter 1: Structural Determinants and Potential Consequences for Intrahepatic Concentrations. Drug Metab Dispos 2020;48:1380-92. [PMID: 33037045 DOI: 10.1124/dmd.120.000170] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 7.5] [Reference Citation Analysis]
12 Koepsell H. Organic Cation Transporters in Health and Disease. Pharmacol Rev 2020;72:253-319. [PMID: 31852803 DOI: 10.1124/pr.118.015578] [Cited by in Crossref: 119] [Cited by in F6Publishing: 123] [Article Influence: 59.5] [Reference Citation Analysis]
13 Ruggiero MJ, Malhotra S, Fenton AW, Swint-kruse L, Karanicolas J, Hagenbuch B. A clinically-relevant polymorphism in the Na+/taurocholate cotransporting polypeptide (NTCP) occurs at a rheostat position.. [DOI: 10.1101/2020.07.02.184424] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Baidya ATK, Ghosh K, Amin SA, Adhikari N, Nirmal J, Jha T, Gayen S. In silico modelling, identification of crucial molecular fingerprints, and prediction of new possible substrates of human organic cationic transporters 1 and 2. New J Chem 2020;44:4129-43. [DOI: 10.1039/c9nj05825g] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
15 Sandoval PJ, Morales M, Secomb TW, Wright SH. Kinetic basis of metformin-MPP interactions with organic cation transporter OCT2. Am J Physiol Renal Physiol 2019;317:F720-34. [PMID: 31313952 DOI: 10.1152/ajprenal.00152.2019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
16 Türková A, Zdrazil B. Current Advances in Studying Clinically Relevant Transporters of the Solute Carrier (SLC) Family by Connecting Computational Modeling and Data Science. Comput Struct Biotechnol J 2019;17:390-405. [PMID: 30976382 DOI: 10.1016/j.csbj.2019.03.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 4.0] [Reference Citation Analysis]